Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    s.l. : American Chemical Society
    Journal of the American Chemical Society 47 (1925), S. 2546-2556 
    ISSN: 1520-5126
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    s.l. : American Chemical Society
    Journal of the American Chemical Society 52 (1930), S. 4164-4164 
    ISSN: 1520-5126
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-0428
    Keywords: Keywords Non-insulin-dependent diabetes mellitus ; mortality ; macrovascular mortality ; von Willebrand-factor ; urine albumin excretion ; HbA1c ; blood pressure ; lipids.
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The 10-year follow-up of the Munich General Practitioner Project was designed as a long-term prospective study to evaluate factors predicting macrovascular and overall mortality in a random cohort of non-insulin-dependent diabetic (NIDDM) patients. Of the original 290 patients (103 males, 187 females, median age 65 years) 92.5 % could be assessed, 103 subjects had died, 58 from macrovascular causes. In an univariate analysis of baseline data, deceased patients, and especially those who died from macrovascular causes had significantly higher fasting blood glucose, HbA1c, von Willebrand-factor protein, urine albumin excretion, and serum β 2-microglobulin, were significantly older, exhibited significantly more ischaemic heart disease (abnormal ECG Minnesota codes), carotid artery and peripheral vascular disease (both determined by ultrasound-Doppler), and had significantly inferior knowledge about diabetes and its treatment. No significant differences were seen for gender, blood pressure, smoking, total cholesterol, triglycerides, HDL-cholesterol, or the use of antidiabetic, antihypertensive or coronary drugs. In a multiple logistic regression analysis, the risk factors for macrovascular death were age, HbA1c and von Willebrand-factor protein. When baseline macrovascular disease was taken into account, carotid artery disease was also a determinant. The main variables from the metabolic syndrome (blood pressure, dyslipidaemia, body mass index) did not enter a multiple logistic regression analysis. The data suggest that age and haemoglobin A1c are major determinants, and that in addition von Willebrand-factor associated endothelial damage is a risk factor for macrovascular mortality in NIDDM patients. [Diabetologia (1996) 39: 1540–1545]
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-0428
    Keywords: Type 2 (non-insulin-dependent) diabetes mellitus ; recent onset of diabetes ; microalbuminuria ; metabolic syndrome ; hypertension ; dyslipoproteinaemia ; peripheral vascular disease
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Still under debate is the prevalence of microalbuminuria in patients with recently diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and its relation to existing macro-vascular disease and the major vascular risk markers. Hence, from a representative sample of 1512 patients with Type 2 diabetes of varied duration (recruited from 22 nonspecialized medical practices of the Greater Munich Area) 68 (26 males, 42 females) of 71 eligible subjects with a known duration of diabetes of up to 17 weeks and not less than 4 weeks were examined in the present study. Median age was 61 (39 to 75) years, prevalence of ischaemic heart disease (case history plus ECG, Minnesota code, Whitehall criteria) 41.2%, and that of peripheral vascular and carotid artery disease (both assessed by ultrasound-Doppler) were 35.3 and 4.4%, respectively. Diabetes was well controlled (HbA1c: 6.9%, 5.6–8.3; fasting blood glucose: 7.7 mmol/l, 5.4–10.4; median±interquartile range IQ), the cardiovascular risk profile was most prominent in terms of triglycerides (3.1 mmol/l, 2.1–4.6, median±IQ range) and systolic blood pressure (164 mm Hg, 140–186, median±IQ range). 13.2% showed signs of urinary tract infection. Of the remainder, 19.0% exhibited microalbuminuria (RIA, 〉30–200 mg/l), and 5.2% macroalbuminuria (〉200 mg/l). Significant correlations (p〈0.05) were found between urinary albumin concentration and β2-microglobubin in serum, systolic blood pressure, serum triglycerides, serum HDL-cholesterol (inversely), HbA1c, and peripheral vascular disease. The results suggest a high prevalence of increased urinary albumin excretion in recently diagnosed Type 2 diabetic patients and a close relationship with several hallmarks of the so-called metabolic syndrome, probably operative in the pre-clinical state of Type 2 diabetes. Based on these observations, increased albuminuria could be a marker of early and accelerated atherosclerosis.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    s.l. : American Chemical Society
    Industrial & engineering chemistry 10 (1918), S. 600-600 
    ISSN: 1520-5045
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology , Process Engineering, Biotechnology, Nutrition Technology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Journal of Molecular and Cellular Cardiology 18 (1986), S. 423-438 
    ISSN: 0022-2828
    Keywords: 2-Deoxyglucose ; Adenosine ; Glucose ; Isolated working heart ; Lactate ; Myocardial hypoxia ; Pyruvate ; Ribose
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1435-1285
    Keywords: Schlüsselwörter Koronare Herzkrankheit – Chronisches Koronarsyndrom – Antithrombotische Therapie – Antikoagulation – Chronische Thrombolyse ; Key words Coronary artery disease – chronic coronary syndromes – antithrombotic therapy – anticoagulation – chronic thrombolytic therapy
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Antithrombotic therapy is a basic part in the treatment of acute as well as chronic coronary syndromes. The rationale is an enhanced platelet activity with predomination of procoagulatory mechanisms in coronary artery disease. The current status of antiplatelet drugs, anticoagulation, and chronic thrombolysis used in the treatment of chronic coronary syndromes is discussed. It is concluded that low-dose aspirin is the current drug of choice for long term oral treatment in patients with stable chronic coronary artery disease. In contrast, oral anticoagulation with coumadin should be considered in patients with higher risk for atrial or ventricular thrombosis. The impact of long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris leads to a marked improvement of clinical symptoms. Oral blockade of platelet membrane glycoprotein IIb/IIIa receptor and clinical trials regarding antiischemic effects of low-molecular weight heparins in chronic coronary syndromes are expected for the future.
    Notes: Zusammenfassung Die antithrombotische Therapie besitzt in der Behandlung von akuten und chronischen Koronarsyndromen einen elementaren Stellenwert. Die Rationale dafür stellt eine verstärkte Thrombozytenaktivierung mit Aktivierung des plasmatischen Gerinnungssystems und damit prokoagulatorischen Mechanismen bei koronarer Herzkrankheit dar. In dieser Arbeit wird der derzeitige Stellenwert der Thrombozytenaggregationshemmung, Antikoagulation und chronischen Thrombolyse in der Therapie von chronischen Koronarsyndromen diskutiert. Derzeit stellt eine niedrig-dosierte Aspirintherapie die Therapie der Wahl bei chronisch stabiler, koronarer Herzkrankheit dar. Darüberhinaus müssen für bestimmte Risikogruppen von Koronarpatienten modifizierte Therapieempfehlungen gegeben werden. So wird eine orale Antikoagulantientherapie bei Patienten empfohlen, welche ein höheres Risiko von muralen Thromben aufweisen. Für die “chronisch-intermittierende Urokinasetherapie” sind exzellente Effekte auf die Verbesserung der klinischen Symptomatik bei therapierefraktären Formen der terminalen koronaren Herzkrankheit beschrieben. Künftige Fortschritte sind von der Einführung oraler Glykoprotein IIb-IIIa-Rezeptorantagonisten und der klinischen Überprüfung antiischämischer Effekte von niedermolekularen Heparinen zu erwarten.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 68 (1990), S. 380-383 
    ISSN: 1432-1440
    Keywords: Prostaglandin E1 infusion ; Amino acid metabolism ; Metabolic effects
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The influence of an intraarterial infusion of PGE1 on the amino acid metabolism of human sceletal muscle was examined in healthy volunteers using the forearm technique. A continuous increase of perfusion from 2.9±0.1 ml/100 g × min to 5.4±1.5 after 60 min could be observed. Muscular amino acid balances were not changed after 30 min but significantly after 60 min of PGE1 infusion. Muscular release of most of the amino acids was reduced or shifted to an uptake. The accumulated balance of the amino acids showed a significant increase from −21.9 to +33.2 nmol/ 100 g × min after 60 min. Thus the infusion of PGE1 led to an inhibition of muscular proteolysis and/or to a stimulation of proteosynthesis. In view of the fact that kinines are released during exercise and are partially effective via prostaglandine liberation, the protein-anabolic effect of exercise might be explained by action of prostaglandins.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    ISSN: 1432-1440
    Keywords: Low-dose thrombolytic therapy ; rt-PA ; Arterial occlusion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The efficacy and safety of recombinant tissue-type plasminogen activator (rt-PA) was evaluated in 46 patients with thrombembolic arterial occlusions in leg arteries. rt-PA was given over 1–4 h with a maximum dose of 18 mg. The effect of rt-PA treatment was determined as patency of the occluded arteries in 44 different patients 14 days after treatment. In 41 patients at least one artery was recanalized (93%) by rt-PA, and in almost half of these patients (48%) no residual stenosis were detected after the lytic treatment. A slight residual stenosis was detected in 29% of the patients and a severe residual stenosis in 21%. An additional treatment with percutaneous transluminal angioplasty was performed in 23 of the 44 patients and successful in 21 (91%). In 8 patients an addition catheter-embolectomy was performed. No difference in patency rate was detected between patients with thrombotic and those with embolic occlusions. The age of the occlusion influenced the patency rate; occlusions under the age of 5 weeks showed a patency rate of 96% compared to 82% in older occlusions. The length of the occlusion did not have any influence on the outcome of the rt-PA treatment. From the results of this open study we conclude that a dose of up to 18 mg of rt-PA is both safe and effective in the treatment of thromboembolic occlusions in leg arteries.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    ISSN: 1432-1289
    Keywords: Schlüsselwörter Koronare Herzkrankheit ; Therapie ; Angina pectoris ; Therapie ; Hypercholesterinämie ; Therapie
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Zusammenfassung In Hinblick auf die medikamentöse Therapie der chronischen Myokardischämie lassen sich kurz- und langfristige Ziele definieren. Zu den kurzfristigen zählen die Verbesserung der koronaren Vasomotion epikardialer Leitungs- und koronarer Widerstandsgefäße, die Reduktion der Thrombozytenaktivierung sowie die Verbesserung der Fibrinolyse und der Rheologie. Langfristige Ziele sind die Plaque-Stabilisierung und die Reduktion kardiovaskulärer Ereignisse. Für den betroffenen Patienten mit koronarer Herzkrankheit äußert sich der Therapieerfolg in einer Besserung der pectanginösen Beschwerden und somit der Lebensqualität.Um diese subjektive Einschätzung korrekter bewerten zu können, bedient man sich gern der Kriterien der CCS (Canadian Cardiovascular Society)-Klassifikation mit 4 Schweregraden der Angina pectoris. Die vorliegende Arbeit gibt einen gedrängten Überblick über die derzeitigen therapeutischen Strategien der chronischen Myokardischämie. Nicht zuletzt wegen der ungeheuren Bedeutung hinsichtlich Morbidität und Mortalität sowie den gravierenden ökonomischen Folgen der koronaren Herzkrankheit kommt der mdedikamentösen Therapie besonderer Stellenwert zu.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...